 Hollis Karoly
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 15 | 2025 | 429 | 4.620 |
Why?
| | Alcohol Drinking | 17 | 2024 | 752 | 3.730 |
Why?
| | Cannabidiol | 6 | 2023 | 91 | 3.030 |
Why?
| | Marijuana Abuse | 7 | 2025 | 229 | 2.440 |
Why?
| | Hallucinogens | 5 | 2023 | 86 | 2.310 |
Why?
| | Cannabinoids | 5 | 2022 | 129 | 2.280 |
Why?
| | Substance-Related Disorders | 10 | 2023 | 1013 | 2.180 |
Why?
| | Alcoholism | 10 | 2025 | 766 | 2.080 |
Why?
| | Ethanol | 10 | 2024 | 584 | 2.050 |
Why?
| | Adolescent Behavior | 6 | 2019 | 505 | 1.790 |
Why?
| | Brain | 10 | 2025 | 2620 | 1.730 |
Why?
| | Gray Matter | 4 | 2021 | 82 | 1.420 |
Why?
| | Marijuana Smoking | 5 | 2023 | 239 | 1.390 |
Why?
| | Marijuana Use | 5 | 2025 | 189 | 1.350 |
Why?
| | Magnetic Resonance Imaging | 13 | 2025 | 3376 | 1.270 |
Why?
| | Neuroimaging | 3 | 2024 | 278 | 1.240 |
Why?
| | Cues | 5 | 2019 | 321 | 1.080 |
Why?
| | Toll-Like Receptor 4 | 2 | 2018 | 262 | 1.010 |
Why?
| | Reagent Strips | 1 | 2025 | 6 | 0.970 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2025 | 43 | 0.950 |
Why?
| | Music | 1 | 2025 | 39 | 0.920 |
Why?
| | Fentanyl | 1 | 2025 | 76 | 0.900 |
Why?
| | Substance Abuse Detection | 1 | 2025 | 72 | 0.900 |
Why?
| | White Matter | 2 | 2021 | 133 | 0.790 |
Why?
| | Alcohol-Related Disorders | 4 | 2021 | 118 | 0.790 |
Why?
| | Reward | 4 | 2018 | 240 | 0.750 |
Why?
| | Dronabinol | 6 | 2023 | 166 | 0.730 |
Why?
| | Behavior, Addictive | 3 | 2019 | 81 | 0.720 |
Why?
| | Alcoholic Intoxication | 1 | 2021 | 63 | 0.670 |
Why?
| | Adolescent Development | 1 | 2019 | 82 | 0.620 |
Why?
| | Therapy, Computer-Assisted | 1 | 2019 | 60 | 0.610 |
Why?
| | Avoidance Learning | 1 | 2019 | 67 | 0.610 |
Why?
| | Students | 1 | 2023 | 572 | 0.590 |
Why?
| | Arousal | 1 | 2018 | 150 | 0.580 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 182 | 0.560 |
Why?
| | Flowers | 3 | 2023 | 58 | 0.550 |
Why?
| | Humans | 47 | 2025 | 128417 | 0.540 |
Why?
| | Adult | 23 | 2025 | 35299 | 0.530 |
Why?
| | Young Adult | 15 | 2025 | 12312 | 0.530 |
Why?
| | Affect | 1 | 2018 | 285 | 0.510 |
Why?
| | Risk-Taking | 2 | 2018 | 347 | 0.510 |
Why?
| | Drug Users | 1 | 2015 | 41 | 0.480 |
Why?
| | Cannabinoid Receptor Agonists | 4 | 2023 | 36 | 0.480 |
Why?
| | Cytokines | 2 | 2025 | 1983 | 0.470 |
Why?
| | Sexual Behavior | 2 | 2018 | 481 | 0.460 |
Why?
| | Adolescent | 14 | 2025 | 20179 | 0.460 |
Why?
| | Motivation | 1 | 2018 | 546 | 0.440 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 126 | 0.430 |
Why?
| | Male | 30 | 2025 | 62857 | 0.430 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2013 | 43 | 0.420 |
Why?
| | Female | 29 | 2025 | 68153 | 0.410 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 633 | 0.390 |
Why?
| | Parenting | 1 | 2015 | 296 | 0.370 |
Why?
| | Extinction, Psychological | 1 | 2012 | 86 | 0.360 |
Why?
| | Universities | 2 | 2023 | 400 | 0.350 |
Why?
| | Analgesics | 2 | 2022 | 163 | 0.350 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2024 | 563 | 0.330 |
Why?
| | Colorado | 3 | 2025 | 4375 | 0.310 |
Why?
| | Double-Blind Method | 3 | 2023 | 1848 | 0.280 |
Why?
| | Tobacco Use | 2 | 2019 | 61 | 0.270 |
Why?
| | Psychomotor Performance | 2 | 2020 | 311 | 0.270 |
Why?
| | Delay Discounting | 2 | 2018 | 18 | 0.270 |
Why?
| | Smoking | 3 | 2018 | 1460 | 0.260 |
Why?
| | Executive Function | 3 | 2020 | 422 | 0.250 |
Why?
| | Middle Aged | 11 | 2025 | 30889 | 0.230 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 5362 | 0.230 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 397 | 0.210 |
Why?
| | Stress, Psychological | 1 | 2012 | 1059 | 0.210 |
Why?
| | Tobacco Use Disorder | 2 | 2017 | 239 | 0.210 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5039 | 0.210 |
Why?
| | Exercise | 2 | 2020 | 1929 | 0.210 |
Why?
| | Biomarkers | 2 | 2025 | 3880 | 0.190 |
Why?
| | Self Report | 2 | 2018 | 801 | 0.190 |
Why?
| | Nerve Net | 2 | 2015 | 256 | 0.180 |
Why?
| | Inflammation | 2 | 2025 | 2654 | 0.180 |
Why?
| | Mindfulness | 1 | 2023 | 114 | 0.180 |
Why?
| | Cross-Over Studies | 1 | 2023 | 513 | 0.180 |
Why?
| | High-Intensity Interval Training | 1 | 2020 | 24 | 0.180 |
Why?
| | Psychomotor Disorders | 1 | 2020 | 17 | 0.180 |
Why?
| | Sensation Disorders | 1 | 2020 | 31 | 0.170 |
Why?
| | Research Design | 1 | 2025 | 1036 | 0.150 |
Why?
| | DNA Methylation | 3 | 2018 | 604 | 0.150 |
Why?
| | Plant Extracts | 1 | 2020 | 179 | 0.150 |
Why?
| | Photic Stimulation | 1 | 2019 | 239 | 0.150 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 385 | 0.140 |
Why?
| | Receptors, Dopamine D2 | 1 | 2018 | 89 | 0.140 |
Why?
| | Varenicline | 1 | 2017 | 26 | 0.140 |
Why?
| | Saliva | 1 | 2018 | 207 | 0.140 |
Why?
| | Methylation | 1 | 2017 | 227 | 0.130 |
Why?
| | Interleukin-8 | 1 | 2018 | 258 | 0.130 |
Why?
| | Corpus Striatum | 1 | 2018 | 155 | 0.130 |
Why?
| | Pregnancy | 3 | 2024 | 6357 | 0.130 |
Why?
| | Interleukin-1beta | 1 | 2018 | 373 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 343 | 0.120 |
Why?
| | Anticipation, Psychological | 1 | 2015 | 22 | 0.120 |
Why?
| | Exploratory Behavior | 1 | 2015 | 86 | 0.120 |
Why?
| | Cerebral Cortex | 1 | 2018 | 423 | 0.120 |
Why?
| | Comorbidity | 1 | 2019 | 1543 | 0.120 |
Why?
| | Heart Rate | 1 | 2018 | 800 | 0.110 |
Why?
| | Brain Mapping | 1 | 2018 | 572 | 0.110 |
Why?
| | Functional Neuroimaging | 1 | 2014 | 73 | 0.110 |
Why?
| | Pilot Projects | 1 | 2019 | 1563 | 0.110 |
Why?
| | Interleukin-6 | 1 | 2018 | 716 | 0.110 |
Why?
| | Retinal Dehydrogenase | 1 | 2013 | 33 | 0.110 |
Why?
| | Drug Interactions | 1 | 2015 | 357 | 0.110 |
Why?
| | Benzodiazepines | 1 | 2014 | 129 | 0.110 |
Why?
| | Animals | 5 | 2019 | 34479 | 0.110 |
Why?
| | Smoking Cessation | 1 | 2017 | 408 | 0.100 |
Why?
| | Antipsychotic Agents | 1 | 2014 | 191 | 0.100 |
Why?
| | Receptors, Nicotinic | 1 | 2014 | 322 | 0.090 |
Why?
| | Blood Pressure | 1 | 2018 | 1728 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2013 | 361 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1212 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 735 | 0.090 |
Why?
| | Siblings | 2 | 2018 | 215 | 0.070 |
Why?
| | Child | 2 | 2024 | 20655 | 0.070 |
Why?
| | Parents | 1 | 2015 | 1304 | 0.070 |
Why?
| | Anxiety | 2 | 2023 | 954 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2017 | 10151 | 0.060 |
Why?
| | Connectome | 1 | 2025 | 84 | 0.050 |
Why?
| | Intention | 1 | 2023 | 162 | 0.050 |
Why?
| | Signal Transduction | 1 | 2015 | 4826 | 0.050 |
Why?
| | Secondary Prevention | 1 | 2023 | 219 | 0.050 |
Why?
| | Harm Reduction | 1 | 2021 | 31 | 0.050 |
Why?
| | Anxiety Disorders | 1 | 2023 | 349 | 0.040 |
Why?
| | Verbal Learning | 1 | 2020 | 64 | 0.040 |
Why?
| | Underage Drinking | 1 | 2019 | 20 | 0.040 |
Why?
| | United States | 1 | 2015 | 13830 | 0.040 |
Why?
| | Postural Balance | 1 | 2020 | 199 | 0.040 |
Why?
| | Hyperkinesis | 1 | 2017 | 17 | 0.040 |
Why?
| | Phenotype | 2 | 2018 | 3044 | 0.040 |
Why?
| | Missouri | 1 | 2017 | 68 | 0.040 |
Why?
| | Southwestern United States | 1 | 2017 | 91 | 0.040 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 236 | 0.030 |
Why?
| | Attention | 1 | 2020 | 434 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 440 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2020 | 413 | 0.030 |
Why?
| | Impulsive Behavior | 1 | 2017 | 128 | 0.030 |
Why?
| | Taste | 1 | 2018 | 208 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2013 | 14454 | 0.030 |
Why?
| | Bayes Theorem | 1 | 2017 | 369 | 0.030 |
Why?
| | Conduct Disorder | 1 | 2017 | 199 | 0.030 |
Why?
| | Craving | 1 | 2014 | 40 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1945 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1198 | 0.030 |
Why?
| | CpG Islands | 1 | 2013 | 152 | 0.030 |
Why?
| | Mothers | 1 | 2017 | 729 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1936 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2721 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4892 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 5388 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3103 | 0.020 |
Why?
| | Aged | 1 | 2020 | 21953 | 0.010 |
Why?
| | Cephalosporins | 1 | 1978 | 35 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1978 | 530 | 0.000 |
Why?
| | Microbial Sensitivity Tests | 1 | 1978 | 332 | 0.000 |
Why?
| | Bacterial Infections | 1 | 1978 | 226 | 0.000 |
Why?
| | Bacteria | 1 | 1978 | 808 | 0.000 |
Why?
| | Mice | 1 | 1978 | 16602 | 0.000 |
Why?
|
|
Karoly's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|